Полинейропатия. Учебное пособие

32.Cheshire W. P., Freeman R., Gibbons C. H. et al. Electrodiagnostic assessment of the autonomic nervous system: A consensus statement endorsed by the American Autonomic Society, American Academy of Neurology, and the International Federation of Clinical Neurophysiology // Clin Neurophysiol. – 2021. – ʋ – Ɋ. 666–682.

33.Zambelis T., Karandreas N., Tzavellas E. et al. Large and small fiber neuropathy in chronic alcohol–dependent subject // J. Peripher. Nerv. Syst. 2005.– Vol. 10, ʋ – P. 375–381.

34.Grewal A.S., Bhardwaj S., Pandita D., Lather V., Sekhon B.S. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non–diabetic Diseases. Mini Rev Med Chem. – 2016. – ʋ 16 (2). – Ɋ 120–162. doi: 10.2174/1389557515666150909143737

35.Gibson W., Wand B.M., O’Connell N.E. Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults. Cochrane Database S.

36.Eftimov F., Winer J. B., Vermeulen M. et al. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy // Cochrane Database Syst Rev. – 2009. – ʋ

37.Ba A. Metabolic and structural role of thiamine in nervous tissues // Cell. Mol. Neurobiol. – 2008. – Vol. 28. – P. 923–931.

38.Mijnhout G.S., Kollen B.J., Alkhalaf A., Kleefstra N., Bilo H.J.G. Alpha lipoic Acid for symptomatic peripheral neuropathy in patients with diabetes: a meta–analysis of randomized controlled trials. Int J Endocrinol. – 2012; 2012:456279. doi: 10.1155/2012/456279.

39.Lee W.Y., Orestes P., Latham J., Naik A.K., Nelson M.T., Vitko I. et al. Molecular mechanisms of lipoic acid modulation of T–type calcium channels in pain pathway. J Neurosci. 2009;29(30):9500–9509. doi: 10.1523/ JNEUROSCI.5803–08.2009.

40.Chopra K., Tiwari V. Alcoholic neuropathy: possible mechanisms and future treatment possibilities // Br. J. Clin. Pharmacol. – 2012. – Vol. 73, ʋ – Ɋ. 348–362.

41.Mixcoatl-Zecuatl T., Quinonez–Bastidas G.N., Caram-Salas N.L. et al. Synergistic antiallodinic interaction between gabapentin or carbamazepine and either benfotiamine or cyanocobalamin in neuropathic rats // Methods Find Exp. Clin. Pharmacol. – 2008. – Vol. 30. – P. 431–441.

91

2025 ɝ.

ɍɱɟɛɧɨɟ ɢɡɞɚɧɢɟ

Ɇɢɪɨɧɟɧɤɨ Ɍ ȼ Ȼɚɛɚɧ ɋ Ɇ Ȼɚɛɢɱɟɜ Ⱥ ȼ Ʉɚɪɩɭɲɢɧ Ⱦ ȼ., ɉɨɥɤɨɜɧɢɤɨɜ ɉ Ɋ Ʉɚɱɤɚɥɨɜɚ ɇ ɇ

ɉɈɅɂɇȿɃɊɈɉȺɌɂə

ɍɱɟɛɧɨɟ ɩɨɫɨɛɢɟ

ɉɨɞ ɪɟɞɚɤɰɢɟɣ ɞ-ɪɚ ɦɟɞ ɧɚɭɤ ɩɪɨɮɟɫɫɨɪɚ Ɍ ȼ Ɇɢɪɨɧɟɧɤɨ

___________________________________________

ɉɨɞɩɢɫɚɧɨ ɜ ɩɟɱɚɬɶ 20.05.2025. Ɏɨɪɦɚɬ î Ȼɭɦɚɝɚ ɤɫɟɪɨɤɫɧɚɹ ɉɟɱɚɬɶ ɨɩɟɪɚɬɢɜɧɚɹ Ɉɛɴɟɦ – 5,7 ɭɫɥ ɩɟɱ ɥ Ɍɢɪɚɠ ɷɤɡ Ɂɚɤɚɡ 82.

Ɉɬɩɟɱɚɬɚɧɨ ɜ ɬɢɩɨɝɪɚɮɢɢ ɂɉ ɂ Ⱥ Ƚɚɩɨɧɨɜɚɝ ɋɚɦɚɪɚ ɭɥ Ɇ Ƚɨɪɶɤɨɝɨ Ɍɟɥ -16-56.

92